Article
Hotspot oncomutations: implications for personalized cancer treatment.
Expert review of molecular diagnostics - 1 Jul 2012
Myers Meagan B, Wang Yiying, McKim Karen L, Parsons Barbara L
Abstract excerpt
Understanding the extent to which specific tumor mutations impact or mediate patient response to particular cancer therapies has become a rapidly increasing area of research. Recent research findings regarding four predominant mutational targets (KRAS, BRAF, EGFR and PIK3CA) show that these tumor mutations have predictive power for identifying which patients are likely to respond to particular therapies, and have...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
